MODULATION OF CD20 ANTIGEN EXPRESSION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AFTER RITUXIMAB THERAPY

被引：0
|
作者：
D'Auria, F. [1 ]
Guariglia, R. [1 ]
Villani, O. [1 ]
Pietrantuono, G. [1 ]
Martorelli, M. [1 ]
Mansueto, G. [1 ]
Grieco, V. [1 ]
Zonno, A. [1 ]
Zifarone, E. [1 ]
Bianchino, G. [1 ]
Di Giovannantonio, L. [1 ]
Vita, G. [1 ]
Musto, P. [1 ]
机构：
[1] IRCCS, Centro Riferimento Oncol Basilicata, Rionero in Vulture, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0791
引用
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
  • [1] Modulation of CD20 Antigen Expression After Rituximab Treatment: A Retrospective Study in Patients With Chronic Lymphocytic Leukemia
    D'Auria, Fiorella
    Guariglia, Roberto
    Villani, Oreste
    Mansueto, Giovanna
    Grieco, Vitina
    Zonno, Antonia
    Bianchino, Gabriella
    Di Giovannantonio, Luigina
    Vita, Giulia
    Musto, Pellegrino
    [J]. CLINICAL THERAPEUTICS, 2010, 32 (11) : 1911 - 1916
  • [2] Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia
    Jilani, I
    O'Brien, S
    Manshuri, T
    Thomas, DA
    Thomazy, VA
    Imam, M
    Naeem, S
    Verstovsek, S
    Kantarjian, H
    Giles, F
    Keating, M
    Albitar, M
    [J]. BLOOD, 2003, 102 (10) : 3514 - 3520
  • [3] CELL SURFACE CD20 ANTIGEN EXPRESSION ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Giordano, A.
    Curci, P.
    Rizzi, R.
    Perrone, T.
    Delia, M.
    Mestice, A.
    Nardelli, G.
    Di Tardo, I.
    Specchia, G.
    [J]. HAEMATOLOGICA, 2013, 98 : 541 - 541
  • [4] REDUCED EXPRESSION OF CD20 ANTIGEN AS A CHARACTERISTIC MARKER FOR CHRONIC LYMPHOCYTIC-LEUKEMIA
    ALMASRI, NM
    DUQUE, RE
    ITURRASPE, J
    EVERETT, E
    BRAYLAN, RC
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1992, 40 (04) : 259 - 263
  • [5] Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia
    Venugopal, P
    Sivaraman, S
    Huang, XK
    Nayini, J
    Gregory, SA
    Preisler, HD
    [J]. LEUKEMIA RESEARCH, 2000, 24 (05) : 411 - 415
  • [6] Emergence of rituximab-fludarabine resistance is associated with changes in CD20 antigen expression-and improved response to almetuzumab therapy in patients with chronic lymphocytic leukemia (CLL)
    Ashraf, Umeer
    Elefante, Anjana N.
    Cruz, Raymond
    Wallace, Paul K.
    Czuczman, Myron S.
    Hernandez-Ilizaliturri, Franciscb J.
    [J]. BLOOD, 2007, 110 (11) : 612A - 612A
  • [7] Reevaluation of CD20 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Bokhari, Shahid
    Silverman, Jan
    Ru, Kun
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (04) : 630 - 631
  • [8] Targeting CD20 in chronic lymphocytic leukemia
    Nahas, Myrna R.
    Arnason, Jon E.
    [J]. BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2015, 5 : 43 - 53
  • [9] Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia
    Aue, Georg
    Lindorfer, Margaret A.
    Beum, Paul V.
    Pawluczkowycz, Andrew W.
    Vire, Berengere
    Hughes, Thomas
    Taylor, Ronald P.
    Wiestner, Adrian
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02): : 329 - 332
  • [10] Effect of interferon-α on CD20 antigen expression of B-cell chronic lymphocytic leukemia
    Sivaraman, S
    Venugopal, P
    Ranganathan, R
    Deshpande, CG
    Huang, X
    Jajeh, A
    Gregory, SA
    O'Brien, T
    Preisler, HD
    [J]. CYTOKINES CELLULAR & MOLECULAR THERAPY, 2000, 6 (02) : 81 - 87
12345